Skip to content

Piè Diabetico

by Difa Cooper S.p.A. EUDAMED

Active European Union

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number3271536123PN9 Basic UDI-DIDate7 Sep 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Certificates

2 certificates · EUDAMED

EUDAMED certificates (2)
  • EPT 0477.MDR.24/5668 Active

    Quality management system EU MDR

    Notified body
    0477
    Issued
    13 Dec 2024
    Expires
    12 Dec 2029
  • EPT 0477.MDR.24/5669 Active

    Technical documentation EU MDR

    Notified body
    0477
    Issued
    13 Dec 2024
    Expires
    12 Dec 2029

Specification

EUDAMED

Device Name
P.O.L. RX Crema, Pie Diabético
Primary DI / UDI-DI
08470001924087
Basic UDI-DI
3271536123PN9
EMDN Code
V9099 Various devices not included in other classes - other
Device Class
Class III
Market of Registration
Spain

Manufacturer details

EUDAMED SRN
IT-MF-000028381

Other devices from Difa Cooper S.p.A.

Properties

  • Animal Tissues

Other properties (12)

  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No